GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indraprastha Medical Corp Ltd (NSE:INDRAMEDCO) » Definitions » 3-Year EBITDA Growth Rate

Indraprastha Medical (NSE:INDRAMEDCO) 3-Year EBITDA Growth Rate : 24.00% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Indraprastha Medical 3-Year EBITDA Growth Rate?

Indraprastha Medical's EBITDA per Share for the three months ended in Dec. 2023 was ₹5.62.

During the past 12 months, Indraprastha Medical's average EBITDA Per Share Growth Rate was 28.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 24.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Indraprastha Medical was 24.00% per year. The lowest was -18.80% per year. And the median was 2.45% per year.


Competitive Comparison of Indraprastha Medical's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Indraprastha Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indraprastha Medical's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Indraprastha Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Indraprastha Medical's 3-Year EBITDA Growth Rate falls into.



Indraprastha Medical 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Indraprastha Medical  (NSE:INDRAMEDCO) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Indraprastha Medical 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Indraprastha Medical's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Indraprastha Medical (NSE:INDRAMEDCO) Business Description

Traded in Other Exchanges
Address
Delhi-Mathura Road, Sarita Vihar, New Delhi, IND, 110 076
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.

Indraprastha Medical (NSE:INDRAMEDCO) Headlines

No Headlines